MedPath

厦门宝瑞药业有限公司

Ownership
-
Established
2022-01-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Fosfomycin Sodium for Injection

Product Name
注射用磷霉素钠
Approval Number
国药准字H20247324
Approval Date
Dec 20, 2024
NMPA

Fosfomycin Sodium for Injection

Product Name
注射用磷霉素钠
Approval Number
国药准字H20247323
Approval Date
Dec 20, 2024
NMPA

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20243214
Approval Date
Feb 23, 2024
NMPA

Fosfomycin Sodium for Injection

Product Name
注射用磷霉素钠
Approval Number
国药准字H44023267
Approval Date
Aug 14, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.